Weiya Xia

The University of Texas MD Anderson Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

73h-index30.3kcitations284works3.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(39), RNA modifications and cancer(38), Cancer-related gene regulation(35), Virus-based gene therapy research(26), Cancer Immunotherapy and Biomarkers(24)

Publications284 total

MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
Science·2025· 2 cited
Expression of Concern for JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
Journal of Clinical Investigation·2025Open Access
WITHDRAWN: Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Molecular Cell·2025· 1 cited
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Molecular Cell·2025Open Access
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models
Journal of Clinical Investigation·2025· 4 citedOpen Access
IDDF2024-ABS-0175 Ribonucleases 1 promotes the polarization of tumor-associated macrophages into anti-inflammatory phenotypes by targeting ALK in hepatocellular carcinoma
2024
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma
Nature Communications·2024· 17 citedOpen Access
Supplementary Table 2 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Data from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Table 3 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Table 3 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Table 4 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Table 4 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Methods from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure 1 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Table 1 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Table 1 from Tamoxifen Downregulates <i>Ets</i> Oncogene Family Members <i>ETV4</i> and <i>ETV5</i> in Benign Breast Tissue: Implications for Durable Risk Reduction
2023Open Access
Supplementary Methods from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure Legends 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figures 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
page 1 of 15Next →

Frequent Co-authors

Mien‐Chie Hung(49), Yongkun Wei(15), Jung-Mao Hsu(14), Gabriel N. Hortobágyi(14), Chia‐Wei Li(13), Jennifer L. Hsu(13), Dung‐Fang Lee(10), Seung-Oe Lim(9), Li-Chuan Chan(9), Yun Wu(9), Qingqing Ding(9), Heng‐Huan Lee(8), Dihua Yu(8), Binhua P. Zhou(7), Jong‐Ho Cha(7), Hirohito Yamaguchi(6), Ayşegül A. Şahin(6), Jer-Yen Yang(6), Chun‐Te Chen(6), Wei-Chao Chang(6)